Treatment of Keratinous Dryness With Glycerides

1 - 31 . (canceled)

32 . Method for preparing a composition for oral and/or parenteral absorption and intended to prevent and/or treat at least one selected from the group consisting of dry and/or delicate keratinous substances, dry and/or delicate skin, itching and/or tightness, cutaneous disorders associated with defective excretion and/or secretion of sebum, dry hypo-seborrheic skin, dry and/or delicate keratinous fibers, functional disorders of the pilo-sebaceous unit, wrinkles associated with cutaneous dryness and/or to stimulate sebogenesis, comprising a step of preparing medium chain glyceride(s) as an active ingredient with a suitable carrier.

33 . Method according to claim 32 , wherein the medium chain glycerides are in the form of a mixture of glycerides the fatty acids of which contain 6 to 12 carbon atoms.

34 . Method according to claim 33 , wherein the fatty acids contain 8 to 10 carbon atoms.

35 . Method according to claim 32 , wherein the fatty acids composing the glycerides contain linear and saturated chains.

36 . Method according to claim 32 , wherein the medium chain glycerides are in the form of a mixture comprising 40% to 90%, by weight of C 8 fatty acids.

37 . Method according to claim 36 , wherein the mixture comprises 45% to 75% by weight of C 8 fatty acids.

38 . Method according to claim 37 , wherein the mixture comprises 50% to 70% by weight of C 8 fatty acids.

39 . Method according to claim 32 , wherein the medium chain glycerides are in the form of a mixture comprising 15% to 60% by weight of C 10 fatty acids.

40 . Method according to claim 39 , wherein the mixture comprises 30% to 50% by weight of C 10 fatty acids.

41 . Method according to claim 32 , wherein the glycerides are in the form of a mixture comprising a maximum of 2% by weight of C 6 fatty acids.

42 . Method according to claim 32 , wherein said glycerides are in the form of a mixture comprising less than 3% of C 12 fatty acids.

43 . Method according to claim 32 , wherein the mixture comprises at most 1% of C 12 fatty acids.

44 . Method according to claim 32 , wherein the medium chain glycerides are selected from the group consisting of medium chain monoglycerides, diglycerides and triglycerides and mixtures thereof.

45 . Method according to claim 32 , wherein the medium chain glycerides are constituted by or comprise at least medium chain triglycerides.

46 . Method according to claim 32 , wherein the glycerides are used in the form of an oil or a mixture of vegetable oils containing them.

47 . Method according to claim 32 , wherein said composition comprises 0.1% to 100% by weight, of medium chain glycerides relative to the total composition weight.

48 . Method according to claim 47 , wherein said composition comprises 15% to 80% by weight of medium chain glycerides relative to the total composition weight.

49 . Method according to claim 48 , wherein said composition comprises 30% to 70% by weight of medium chain glycerides relative to the total composition weight.

50 . Method according to claim 32 , wherein said composition is intended for oral administration.

51 . Method according to claim 32 , wherein the composition is in the form of a food supplement, a nutritional composition or in the form of a functional food for the treatment of keratinous substances intended for humans or animals.

52 . A composition for oral absorption for the prevention and/or treatment of dry and/or sensitized keratinous substances, wherein it comprises, as an active ingredient, at least one medium chain glyceride and at least one other agent that is active on keratinous substances.

53 . A composition according to claim 52 , wherein said active agent is selected from the group consisting of vitamins, minerals, essential lipids and their derivatives, in particular conjugated linoleic acid, caprenin, oligoelements, polyphenols, flavonoids, phyto-estrogens, antioxidants such as lipoic acid and coenzyme Q10, carotenoids, probiotics, prebiotics, proteins and amino acids, mono- and polysaccharides, amino-sugars, phytosterols and triterpene alcohols of vegetable origin.

54 . A composition according to claim 52 , wherein the medium chain glycerides are in the form of a mixture of glycerides the fatty acids of which contain 6 to 12 carbon atoms.

55 . Method for preparing a non-therapeutic composition to prevent and/or treat dry and/or delicate keratinous substances, and/or to treat and/or prevent cutaneous disorders and/or disorders of the pilo-sebaceous unit associated with a defect in sebum excretion and/or secretion and/or to treat hypo-seborrheic dry skin and/or to prevent and/or treat itching and/or tightness and/or to stimulate sebogenesis and/or to prevent and/or treat dry or delicate keratinous fibers and/or to prevent and/or reduce wrinkles associated with cutaneous dryness, comprising a step of preparing medium chain glycerides as an active ingredient with a suitable carrier.

56 . Method according to claim 55 , wherein medium chain triglycerides are used.

57 . A non-therapeutic treatment method to prevent and/or treat dry and/or delicate keratinous substances, and/or to treat dry hypo-seborrheic skin and/or to prevent and/or treat itching and/or tightness and/or to stimulate sebogenesis and/or to treat and/or prevent cutaneous disorders and/or disorders of the pilo-sebaceous unit associated with a defect in sebum excretion and/or secretion and/or to prevent and/or treat dry or delicate keratinous fibers and/or to prevent and/or reduce wrinkles associated with cutaneous dryness, comprising administering at least an effective quantity of medium chain glyceride(s).

58 . A method according to claim 57 , wherein medium chain triglyceride(s) are used.

59 . A method according to claim 57 , wherein the medium chain glycerides are administered in daily doses of 0.5 mg/day to 100 g/day

60 . A method according to claim 59 , wherein the medium chain glycerides are administered in daily doses of 1 mg/day to 10 g/day.

61 . A method according to claim 60 , wherein the medium chain glycerides are administered in daily doses of 5 to 2.5 g/day.

62 . A method according to claim 55 , wherein the medium chain triglycerides are administered orally and/or parenterally.

63 . A method according to claim 55 , wherein it comprises joint topical administration of medium chain glycerides.